Page last updated: 2024-11-03

probenecid and Brill Disease

probenecid has been researched along with Brill Disease in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
"11 registered thyphoid carriers were treated by cholecystectomy combined with amoxycillin + probenecid in our department."1.26Curing of typhoid carriers by cholecystectomy combined with amoxycillin plus probenecid treatment. ( Békési, S; Münnich, D, 1979)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Münnich, D1
Békési, S1

Other Studies

1 other study available for probenecid and Brill Disease

ArticleYear
Curing of typhoid carriers by cholecystectomy combined with amoxycillin plus probenecid treatment.
    Chemotherapy, 1979, Volume: 25, Issue:6

    Topics: Adult; Aged; Amoxicillin; Carrier State; Cholecystectomy; Drug Therapy, Combination; Female; Follow-

1979